Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase (Q44992838)

8 December 2017

title

Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase (English)

1 reference

8 December 2017

1 reference

S-H Lim

1

1 reference

8 December 2017

S A Choi

2

1 reference

8 December 2017

J Y Lee

3

1 reference

8 December 2017

K-C Wang

4

1 reference

8 December 2017

J H Phi

5

1 reference

8 December 2017

D-H Lee

6

1 reference

8 December 2017

S H Song

7

1 reference

8 December 2017

J H Song

8

1 reference

8 December 2017

X Jin

9

1 reference

8 December 2017

H Kim

10

1 reference

8 December 2017

H J Lee

11

1 reference

8 December 2017

I Lim

12

1 reference

8 December 2017

S U Kim

13

1 reference

8 December 2017

S-K Kim

14

1 reference

8 December 2017

publication date

26 August 2011

1 reference

8 December 2017

1 reference

8 December 2017

volume

18

1 reference

8 December 2017

issue

11

1 reference

8 December 2017

page(s)

817-824

1 reference

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Radiation therapy in the management of childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Development of a tumor-selective approach to treat metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

From bench to bedside for gene-directed enzyme prodrug therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Production and characterization of immortal human neural stem cell line with multipotent differentiation property

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Stem cell-based cell therapy in neurological diseases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Establishment of an in vivo meningioma model with human telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

Results of radiosurgery in the management of recurrent and residual medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

inferred from DOI database lookup

7 January 2021

based on heuristic

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

inferred from DOI database lookup

7 January 2021

based on heuristic

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.52

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.52

1 reference

Dimensions Publication ID

8 December 2017

1043605597

0 references

1 reference